CN210192613U - Mobile device of intelligent high-flux tumor screening and analyzing platform - Google Patents
Mobile device of intelligent high-flux tumor screening and analyzing platform Download PDFInfo
- Publication number
- CN210192613U CN210192613U CN201921007954.XU CN201921007954U CN210192613U CN 210192613 U CN210192613 U CN 210192613U CN 201921007954 U CN201921007954 U CN 201921007954U CN 210192613 U CN210192613 U CN 210192613U
- Authority
- CN
- China
- Prior art keywords
- tumor
- examination
- tumor screening
- mobile device
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
The utility model discloses a mobile device of an intelligent high-flux tumor screening and analyzing platform, which is provided with a circular or elliptical ring-shaped track (1), wherein a plurality of trolleys (2) are arranged on the track (1), and the trolleys (2) move on the track (1) through rollers at the lower part; a plurality of examination instruments and devices (3) in the tumor screening and analyzing platform are fixed on a trolley (2). By adopting the technical scheme, the detection instrument is convenient to move, so that the patient is prevented from being inflicted by back-and-forth running waves, the diagnosis efficiency is improved, the tumor is strived for being discovered as early as possible, the early effective treatment of the tumor is ensured, the diagnosis and treatment effect is improved, and the pain of the patient and family members is relieved.
Description
Technical Field
The utility model belongs to the technical field of medical science inspection. More specifically, the utility model relates to an intelligence high flux tumour screening analysis platform's mobile device.
Background
Tumors, particularly malignant tumors, are serious diseases, and bring great pain and economic burden to patients and family members. Many types of malignant tumors have no very effective treatment for the tumor at present. The tumors have benign and malignant scores, and a plurality of methods are available for detecting the tumors, and tumor screening is an important way for early detecting cancers and precancerous lesions. Various blood examination indexes, B-ultrasonic examination, X-ray examination, anorectal examination, pap smear and mammary gland molybdenum-palladium photograph in gynecological examination are common methods for screening tumors.
However, in the prior art, the instruments and devices for these tests are fixedly installed, and the patient needs to walk to each instrument to test, which is very inconvenient for some patients with serious diseases and poor physical strength.
SUMMERY OF THE UTILITY MODEL
The utility model provides an intelligence high flux tumour screening analysis platform, its purpose realizes detecting instrument's convenient removal, makes the patient avoid the book Teng who makes a round trip to rush the ripples.
In order to realize the purpose, the utility model discloses the technical scheme who takes does:
the utility model discloses a mobile device of an intelligent high-flux tumor screening and analyzing platform, which is provided with a circular or elliptical ring-shaped track, a plurality of trolleys are arranged on the track, and the trolleys move on the track through rollers at the lower part; a plurality of examination instruments and devices in the tumor screening and analyzing platform are fixed on the trolley.
And each trolley is provided with a driving machine for driving the idler wheel to rotate.
The driving machine is in signal connection with the tumor screening and analyzing platform computer detection and analysis unit.
The front of the inspection instrument and the device, i.e. the display screen and the mounting surface of the operating device, are arranged on the outer surface facing the circular or elliptical ring.
And a patient seat or an examination sickbed is arranged on the outer side of the circular ring or the elliptical ring.
A display of the current examination item is arranged at a position close to a seat or an examination sickbed; the display of the current examination item is in signal connection with the computer detection and analysis unit of the tumor screening and analysis platform.
The above technical scheme is adopted in the utility model, detecting instrument's convenient removal makes the patient avoid making a round trip to rush over the wave the book soars, has improved diagnostic efficiency, strives for the discovery as early as possible of tumour, ensures that the tumour obtains effective treatment in the early stage, improves the diagnosis and treatment effect, alleviates patient and family members' misery.
Drawings
The contents of the drawings and the reference numbers in the drawings are briefly described as follows:
FIG. 1 is a schematic structural diagram of the present invention.
Labeled as:
1. track, 2, trolley, 3, inspection instrument and device, 4, seat, 5, display of current inspection item.
Detailed Description
The following examples are provided to illustrate specific embodiments of the present invention in further detail to help those skilled in the art to understand the inventive concepts and technical solutions of the present invention more completely, accurately and deeply.
Fig. 1 is the utility model relates to an intelligence high flux tumour screening analysis platform mobile device.
In order to solve the problems existing in the prior art and overcome the defects thereof, the utility model realizes the convenient movement of the detecting instrument and prevents the patient from the soaring invention purpose of running back and forth, and the technical proposal adopted by the utility model is that:
the utility model discloses a mobile device of intelligent high-flux tumor screening and analyzing platform, which is provided with a circular or elliptical ring-shaped track 1, a plurality of trolleys 2 are arranged on the track 1, and the trolleys 2 move on the track 1 through rollers at the lower part; a plurality of examination instruments and devices 3 in the tumor screening and analyzing platform are fixed on a trolley 2.
The convenient removal of detecting instrument makes the patient avoid the wriggling of making a round trip to rush, has improved the efficiency of diagnosis, strives for the discovery of the tumour as early as possible, ensures that the tumour is effectively treated early, improves diagnosis and treatment effect, alleviates patient and family members' misery.
The power lines and the signal lines of the inspection instrument and the device 3 are flexibly connected with the power supply and the signal source.
Each trolley 2 is provided with a driving machine for driving the idler wheels to rotate.
The driving machine is in signal connection with a computer detection and analysis unit of the tumor screening and analysis platform. And the computer detects the analysis unit to control.
The front side of the inspection device and apparatus 3, i.e. the display screen and the operating means thereof, is arranged on the outer surface facing the circular or elliptical ring.
On the outside of the circular or elliptical ring, a patient's seat 4 or an examination couch is provided.
A display 5 for the current examination item is arranged at the position close to the seat 4 or the examination sickbed; the display 5 of the current examination item is in signal connection with the computer detection and analysis unit of the tumor screening and analysis platform.
The utility model discloses an intelligent high-throughput tumor screening and analyzing platform, which comprises a blood examination device, a B-type ultrasonic detection device, a PET-CT diagnostic apparatus, a gynecological examination pap smear detector, a gastroscope device, an enteroscope device, a tumor marker screening and detecting device, a bone scanning device and an infrared scanner; the blood examination device, the B-type ultrasonic detection device, the PET-CT diagnostic apparatus, the gynecological examination pap smear detector, the gastroscope device, the enteroscope device, the tumor marker screening detection device, the bone scanning device and the infrared scanner are all connected with the computer detection and analysis unit through signal lines.
The utility model discloses can be in the tumour early quick, comprehensive and accurately obtain tumour inspection result, improve screening efficiency, strive for the discovery of tumour as early as possible, ensure that the tumour obtains effective treatment in early, improve the diagnosis and treatment effect, alleviate the misery of patient and family members.
The blood examination is an important means for detecting early cancer in physical examination, and various malignant tumors can be found and identified by detecting whether the indexes of various tumor markers in blood are increased.
Pap smear in gynecological examination: early cervical carcinoma can be detected by adopting a Papanicolaou staining method, and the detection rate is about 60-70%. By using the color Doppler imaging technology, whether most organs of the whole body have the tumor and the lesion can be clearly found. Gastroscopy and enteroscopy: directly observing the color and luster, the vascular texture and the gland opening shape of the gastric and intestinal mucosa by naked eyes to identify whether pathological changes exist, and performing biopsy to confirm the suspicious focus. PET-CT perfectly integrates PET and CT, PET provides detailed function and metabolism of focus, CT provides accurate anatomical location of focus, tomographic image of whole body in all directions can be obtained by once imaging, and the PET-CT has the characteristics of sensitivity, accuracy, specificity, accurate location and the like, can clearly understand the whole condition of the whole body, and achieves the purposes of early focus finding and disease diagnosis.
The computer detection and analysis unit processes and analyzes the data of the signals collected by the instrument device.
The tumor screening and analyzing platform is provided with a human-computer interaction module, and the human-computer interaction module is provided with a display device and an input device; and the display device and the input device are in signal connection with the computer detection and analysis unit.
The tumor marker comprises serum carcinoembryonic antigen CEA, alpha fetoprotein AFP, prostate specific antigen PSA and chorionic gonadotropin HCG.
Tumor marker screening:
for example: the screening of the monohydroxyphenol substance generally belongs to a broad-spectrum means, needs to be carried out by matching with the specific conditions and symptoms of a body, and has certain probability.
For another example: the alpha-fetoprotein AFP can be used for detecting primary hepatocellular carcinoma and gonadal embryonic tumor. When carcinoembryonic antigen CEA is obviously increased, colon cancer, gastric cancer, lung cancer and bile duct cancer are common; liver cancer, breast cancer, ovarian cancer and pancreatic cancer are also increased.
Long-term smoking or toxic and harmful gas exposure history, regular chest x-ray examination and tumor marker (CEA, SCC, NSE, TPA) combined examination. The middle-aged women regularly perform infrared mammary gland scanning examination and tumor marker (CEA, CAl5-3, TPA) combined examination. If the tumor is obvious, the breast is punctured to examine cancer cells. There is a history of chronic gastric diseases as combined examination of gastroscope and tumor markers (CEA, CA72-4, CA19-9, CA 242). Taking gastric mucosa tissue biopsy under an electron microscope for confirmation. The pancreatic cancer is easy to misdiagnose clinically, and the pancreatic cancer is suspected to be subjected to combined examination of B-ultrasonic and tumor markers (CEA, CAl 9. The continuous hematochezia patients were selected as tumor markers (CEA, CAl9-9, CA50) for combined examination. The rectal tissue biopsy is confirmed. Suspected to be combined inspection of B-ultrasonic and tumor markers (CEA, CAl25, CAl9-9) of ovarian cancer; and (4) taking ovarian tissue biopsy through a laparoscope for confirmation.
If the liver cancer is in a high incidence area or has chronic viral hepatitis (particularly hepatitis B and hepatitis C), the combined examination of the five markers of B-type ultrasonography, hepatitis B and tumor markers (AFP, AFU) should be performed.
Women over 35 years old and people at high risk of cervical cancer caused by Human Papillomavirus (HPV) infection are regularly checked by cytology of vaginal exfoliation or by combined examination of thin-layer cell slide examination (TCT) and tumor markers (SCC, CAl25 and TPA). The diagnosis is confirmed by taking a pathological biopsy under a colposcope.
In the high incidence area of nasopharyngeal carcinoma, the diagnosis should be confirmed by periodic virus examination, and optionally by cytological puncture examination and pathological biopsy. Middle-aged and elderly men are susceptible to prostate cancer and need tumor marker (PSA) combined examination. If dizziness, low fever, pale complexion, anemia, hepatomegaly, splenomegaly and lymph node enlargement, hemorrhage or bleeding spots occur frequently, the routine blood examination and blood cell smear examination are the most convenient and practical. If the blood picture indicates that there is malignant tumor in the blood system, the diagnosis can be made by taking the point of bone marrow and performing cytological examination.
The tumor marker heat shock protein 90 α (Hsp90 α) is positively correlated with tumor malignancy, and the patient can be detected whether the patient has cancer by only taking a drop of blood.
Tumor screening analysis platform include blood inspection device, B type ultrasonic detection device, PET-CT diagnostic equipment, gynaecology's physical examination babbit smear detector, gastroscope device, intestines mirror device, tumor marker screening detection device, bone scanning device, infrared scanner and computer detection analysis unit all install tumor screening analysis platform's organism on to fasten on the organism through connection structure, this connection structure is detachable connection structure.
The above is an exemplary description of the present invention, and it is obvious that the present invention is not limited by the above-mentioned manner, as long as the present invention adopts various insubstantial improvements of the method concept and technical solution, or the present invention is directly applied to other occasions without improvement, all within the protection scope of the present invention.
Claims (6)
1. A mobile device of an intelligent high-throughput tumor screening and analyzing platform is characterized in that: the moving device is provided with a circular or elliptical track (1), a plurality of trolleys (2) are arranged on the track (1), and the trolleys (2) move on the track (1) through rollers at the lower part; a plurality of examination instruments and devices (3) in the tumor screening and analyzing platform are fixed on a trolley (2).
2. The mobile device of an intelligent high-throughput tumor screening and analysis platform of claim 1, wherein: each trolley (2) is provided with a driving machine for driving the idler wheel to rotate.
3. The mobile device of an intelligent high-throughput tumor screening and analysis platform of claim 2, wherein: the driving machine is in signal connection with a computer detection and analysis unit of the tumor screening and analysis platform.
4. The mobile device of an intelligent high-throughput tumor screening and analysis platform of claim 1, wherein: the front of the inspection instrument and device (3), i.e. the display screen and the mounting surface of the operating device, are arranged on the outer surface facing the circular or elliptical ring.
5. The mobile device of an intelligent high-throughput tumor screening and analysis platform of claim 1, wherein: and a patient seat (4) or an examination sickbed is arranged on the outer side of the circular ring or the elliptical ring.
6. The mobile device of an intelligent high-throughput tumor screening and analysis platform of claim 5, wherein: a display (5) of the current examination item is arranged at the position close to the seat (4) or the examination sickbed; the display (5) of the current examination item is in signal connection with the computer detection and analysis unit of the tumor screening and analysis platform.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921007954.XU CN210192613U (en) | 2019-07-01 | 2019-07-01 | Mobile device of intelligent high-flux tumor screening and analyzing platform |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921007954.XU CN210192613U (en) | 2019-07-01 | 2019-07-01 | Mobile device of intelligent high-flux tumor screening and analyzing platform |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN210192613U true CN210192613U (en) | 2020-03-27 |
Family
ID=69869835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201921007954.XU Active CN210192613U (en) | 2019-07-01 | 2019-07-01 | Mobile device of intelligent high-flux tumor screening and analyzing platform |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN210192613U (en) |
-
2019
- 2019-07-01 CN CN201921007954.XU patent/CN210192613U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gorospe et al. | Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients | |
| Yamabe et al. | Usefulness of endoscopic ultrasound-guided fine-needle aspiration with a forward-viewing and curved linear-array echoendoscope for small gastrointestinal subepithelial lesions | |
| Wierzbicka et al. | Comparison of positron emission tomography/computed tomography imaging and ultrasound in surveillance of head and neck cancer–The 3-year experience of the ENT Department in Poznan | |
| Dietrich et al. | What should be known prior to performing EUS exams?(Part II) | |
| Polkowski et al. | Transabdominal ultrasound for visualizing gastric submucosal tumors diagnosed by endosonography: can surveillance be simplified? | |
| CN210192613U (en) | Mobile device of intelligent high-flux tumor screening and analyzing platform | |
| Li et al. | Comparative analysis for diagnostic yield of small cell lung cancer by cytology and histology during the same bronchoscopic procedure | |
| CN110313935A (en) | A kind of high-throughput tumor screening analysis platform of intelligence | |
| Jeevanandam et al. | A comparison of direct brush cytology and biopsy in the diagnosis of colorectal cancer | |
| Liu et al. | Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer | |
| Wagner et al. | Endoscopic submucosal dissection (ESD) for anal high-grade intraepithelial neoplasia: a case report | |
| Mallery et al. | Current status of diagnostic and therapeutic endoscopic ultrasonography | |
| Eberhardt | Ebus guidance for peripheral biopsies | |
| CN110367999B (en) | Breast blood oxygen function imaging assisted with thermal therapy early-stage breast cancer detection system | |
| CN112998651B (en) | Application of photoacoustic imaging in breast tumor scoring system and scoring system | |
| Kornovski et al. | 571 Prognostic factors for HSIL resection margin involvement after LLETZ procedure | |
| Bamiyinoluwa | Lymph Node Evaluation and Metastatic Disease Detection | |
| Zaafouri et al. | Ultrasound Modality in the Evaluation and Management of Gallbladder Polyps | |
| Stephens et al. | Investigations that may be useful in detecting cancer | |
| Inkster et al. | Detection of anal dysplasia by chromoendoscopy with narrow band imaging and acetic acid (NBIA) in 182 patients | |
| Mirza | Management of the Unknown Primary in Head and Neck Cancer | |
| Ott | Pancreatic tumors: efficacy of newer CT techniques matches that of endoscopic sonography | |
| Kongkam et al. | Diagnosis of recurrent rectal cancer deep into the vaginal wall by transvaginal endoscopic ultrasound-guided fine needle aspiration | |
| Fillon | Noninvasive biopsies may be faster and more effective for diagnosing HPV-associated head and neck cancer | |
| Bakhtiyorovna et al. | MEDICINE AND PHARMACY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |